chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Ongoing pain to joints muscles worsened after vaccine with weakness to muscles; Mild swelling to face severly dialated pupils; Mild swelling to face severly dialated pupils; arthritis has worsened severely since vaccine/Joint pain worse also guess it was permanent became it has lasted over 3 months now; became very ill; This is a spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP letter sent to her via follow-up letter in reference case from there this case split for mother. A female patient of an unspecified age received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 23Jan2021 as dose 1, single for covid-19 immunisation. Medical history included endometrial cancer from 08Feb2015 (15Feb2015 after surgery), rheumatoid arthritis and ongoing inflammatory arthritis (10 years ago), gastroparesis (12 years ago), hyperlipidwmia (30 years ago), fibromyalgia (30 years ago) and raynaud's disease (5 years ago). Vaccine facility type was Doctor's office. Vaccine not administered at military facility. The patient's concomitant medications were not reported. The patient experienced became very ill after first vaccine on Jan2021 for 3 weeks refused 2nd vaccine. It was reported that mild swelling to face severely dilated pupils stated or noticed 1:30 hr after vaccine on 23Jan2021 02:30. Resolved several hour later. 2-3 days after vaccine started having muscles weakness and pain to muscles and joints on 26Jan2021 have never experienced this severity before lasted 3 weeks improved but arthritis has worsened severely since vaccine. Joint pain worse also guess it was permanent became it has lasted over 3 months now on Jan2021. The patient has appointment with rheumatologist. Treatment was not received for events mild swelling to face severely dilated pupils. The patient underwent lab tests and procedures which included sara-cov-2 semi quant with unknown result on 16Feb2021, 23Feb2021, 01Mar2021 and 15Apr2021. The outcome of events ongoing pain to joints muscles worsened after vaccine with weakness to muscles was resolved with sequel and mild swelling to face severely dialated pupils was resolved on Jan2021 and other events was unknown.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
pt recv vax 10NOV94 & began having sz;pt had 46 sz in 1995, 46 sz in 1996 & many sz in 1997;pt is recv 2 anticonvulsant drugs & may require neurosurgery to treat the sz;pt is developmentally delayed;
pt recvd vax 1nov94, devel malaise,on nov694 devel confusion & fever;admitted to hosp & underwent lumbar puncture which showed lymphocytic pleocytosis;tx w/atb/acyclovir,bacterial & viral cultures are pending;improved as of 8nov94;
NIGHTMARES; TALKING IN HIS SLEEP; RESTLESSNESS AND THRASHING ABOUT/ ASLEEP, HE THRASHES AROUND LIKE FISH OUT OF WATER; NO ENERGY; FEVER; FATIGUE; This spontaneous report received from a consumer concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 15:00 to right arm for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced fever. On 03-APR-2021, the subject experienced nightmares. On 03-APR-2021, the subject experienced fatigue. On 03-APR-2021, the subject experienced talking in his sleep. On 03-APR-2021, the subject experienced restlessness and thrashing about/ asleep, he thrashes around like fish out of water. On 03-APR-2021, the subject experienced no energy. Laboratory data included: Body temperature (NR: not provided) 102 F. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, nightmares, fatigue, talking in his sleep, restlessness and thrashing about/ asleep, he thrashes around like fish out of water, and no energy. This report was non-serious.
Information has been received from a physician's office employee concerning an adult male who on 10/30/02 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot # 6075M - invalid). On approximately 10/30/02 the patient developed swelling, redness, and soreness on the arm where he received the shot. The patient sought unspecified medical attention. It was reported that another adult male patient had a similar reaction. Additional information has been requested.
49-year-old male who presents with shortness of breath.  This started about 2 weeks ago.  He says he stayed home for about a week with his symptoms knowing that he had COVID-19 infection.  He presented to Hospital a few days ago.  There he was admitted for 3 days and subsequently discharged home.  He was found to have COVID-19 pneumonia.  He remained on room air and never developed hypoxemia.  He was out of the window for remdesivir or IV monoclonal antibody administration.  He did not receive any dexamethasone since he was never hypoxic.  Now he presents to this hospital with worsening shortness of breath.  On presentation his oxygen saturation was in the mid 70% range on room air.  He is now on high flow oxygen cannula with oxygen saturations in the low 90% range.  He has had a dry cough.  He has had extreme fatigue and myalgias but denies any fever or hemoptysis.
chills; fever blisters; This is a spontaneous report from a contactable Consumer reporting for a patient. A female patient of an unspecified age (Age: 76, unit: unspecified) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at SINGLE DOSE (second dose) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for covid-19 immunisation. The reporter stated that her friend has had the second dose of the PFIZER COVID-19 vaccine and had chills the first night and at the end of the second week (14 days) she broke out in fever blisters in her mouth and is on an antibiotic because of the fever blisters. Outcome of the events was unknown. Reporter wanted to know if this is a side effect of the vaccine. Reporter considered the event was non-serious.  Information on the lot/batch number has been requested.
Patient developed a headache with blurred vision several hours after the vaccine.  Denied COVID-19 virus in past.  States she has been taking Tylenol every morning and felt better.  Advised to get Covid-19 Test done.  She went on 8/24/2021, test results were negative. Scheduled for 2nd vaccine on 9/7/2021, but did not show and cancelled appointment due to headaches and bad sweat x 2 days.  Seen by orthopedic doctor on 9/29/2021 who questioned whether she had a TIA.  scheduled for a MRI of neck on 10/5/2021 which was cancelled. due to insurance.  Still with Headaches off and on.  MRI was done on 10/12/2021, no results yet.  Scheduled for follow up appointment with doctor on 11/5/2021.  Patient called weekly with no return call.  Last call made on 11/8/2021, did not answer.  Will close case.
Very swollen injection site. Red (about 2in. In dia) itchy. Severe fatigue, headache, body aches., dizziness.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 57-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 56 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High LDL" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid on 17Oct2023. Clinical Course: Patient had no known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300333486 same patient, different drug /event;
Tops of toes turning white then blue, cold and now also involves most of the foot.  It started approximately 1 week after first dose.  It appeared to be worse after the second dose.
arm was sensitive; red arm; arm a little bit swollen; injection site is redder (4 inches long); arm warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen), VACCINATION SITE WARMTH (arm warm to the touch) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol (Medicine taking for cholesterol) and Stye (Taking eyedrops). Concomitant products included NEOMYCIN and POLYMYXIN for Stye.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)). On an unknown date, the patient experienced VACCINATION SITE WARMTH (arm warm to the touch). At the time of the report, LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen), VACCINATION SITE WARMTH (arm warm to the touch) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication, cholesterol and is taking some eyedrops for a stye (inflammation of the eyelid). Treatment medication included ice on the arm.
I started getting hives all over my body Sunday night. They go away and come back every few hours. I also have difficulty breathing when I have them.
Diagnosed with cellulitis of right leg at vaccine injection site. Treated in ER and given Rx for BACTRIM 40-200mg/5ml oral suspension. Take 2.5 ml orally every 12 hours for 10 days.
I had this and it lasted 2 weeks; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got shingles and after shingles shot which lasted for 2 weeks and had no real pain. The patient said he/she will not be getting another one.
Headache; Not feeling well for a day; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Headache"; MALAISE (non-serious) with onset 2021, outcome "unknown", described as "Not feeling well for a day".  Additional information: Patient had was, just headache like mild.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sore arm after tetanus immunization, onset about 20 hours post immunization,  donor had chills and a fever up to 101.3 F that lasted about 2 days.
Developed right lower extremity swelling and pain two days after vaccine (8/5/2021). Diagnosed with right lower extremity DVT on 8/6/2021
Headache, tiredness, and lethargy the following day.  Dissipated by evening.
Visión con puntos negros, menstruación con flujo mayor y gran cantidad de coágulos, migraña
BALLS BLEW UP TO ABOUT THE SIZE OF A BASEBALL; This spontaneous report received from a patient via a social media  via a company representative concerned a male of unspecified age. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2.s (dose number in series 1, unspecified manufacturer) (suspension for injection, route of admin and batch number were not reported) dose not reported, 1 total, start therapy date was not reported for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2, unspecified manufacturer) (suspension for injection, route of admin and batch number were not reported) dose not reported, 1 total, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2), the patient had testicles blew up to about the size of a baseball. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of testicles blew up to about the size of a baseball was not reported. This report was non-serious.
felt flushed, tingly and numb left arm and left side of face and head. Took me to ER, checked for stroke signs, hooked up to monitors and Given IV steroids, Benadryl and Pepcid.   Watched for a few hours then sent me home.
This spontaneous report as received from registered nurse refers to unspecified patients of unknown ages and genders who on unknown date in January 2015 (reported as since 21-JAN-2015) were vaccinated with a doses of GARDASIL, intramuscular (dose, lot# and expiration date were not reported) which underwent a supported temperature excursion. No adverse effects were reported. It was unknown if the patients sought medical attention. This is one of several reports from the same source. Additional information has been requested.
Became very sore the evening of shot. Still as sore or worse the next day. Became hot and fevered at shot site the next evening with a lump. Blood sugar was very high and couldn?t get insulin to make it come down.
rash; tired; sore; dont want to wake; flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash all up the right side of leg, very tired, sore, didn't want to wake up and flu like symptoms on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
This case linked with AER # 2012-11732 belongs for same patient event occurred after the ADACEL vaccine. Initial report received from a healthcare professional on 19 February 2013. A less than 2 year old female patient, who had no illness at the time of vaccination and unknown medical history and concomitant medications were not reported, had received a dose of Tdap (lot number, dose number, route and site of administration were not reported) on an unspecified date. On an unspecified date, patient had experienced swelling in arm. Corrective treatments and relevant diagnostic tests were not reported. The patient's outcome was not reported. Documents held by sender: None.
Subsequent to receiving vax, the pt developed a mild form of chicken pox with approximately 3 lesions. The pt sought unspecified medical Treatment. Additionally the reporter noted that there was an outbreak of chicken pox within the school district approximately 10 - 20 days before the pt developed chicken pox. No further information is available.
Hive outbreak, first ever, lasting a week, continuing and subsiding slowly.  Large colorless welts. Benadryl and calamine lotion, oatmeal bath.
Parent noticed wrong date of birth on discharge paperwork, after client was given COVID vaccine.  Client date of birth date, discharge paperwork had other date.  There is a difference in dosage for the vaccine based on age.  Client is not having any reactions at this time.  Parent made aware to continue to monitor client.  Parent made facility aware of wrong DOB and is awaiting a call back from the facility.
client was inadvertently given a full 0.5 ml dose for a booster instead of a 0.25 ml dose. Right product but wrong dose amount.
Medical assistant reported in december of 2019, the patient had a change in her diagnosis to immunocompromised and was supposed to be administered a dose of PREVNAR 13 but was administered a second dose of PNEUMOVAX23; the patient was administered a dose of PNEUMOVAX23 two years ago/but was administered a second dose of PNEUMOVAX23 instead by mistake in December of 2019; was supposed to administered a  dose of PREVNAR 13 but was administered a second dose of PNEUMOVAX23 instead by mistake in December of 2019; Medical assistant reported the patient was administered a dose of PNEUMOVAX23 two years ago when the patient was 30 years old because she was a smoker; Medical assistant reported the patient was administered a dose of PNEUMOVAX23 two years ago when the patient was 30 years old; This spontaneous report was received from a medical assistant regarding a female patient in her thirties. The patient's pertinent medical history, previously drug reactions, allergies, and concomitant therapies were unknown by the reporter.   On an unspecified date in 2018 (reported as " two years ago"), when the patient was 30 years old was vaccinated with one dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection, because she was a smoker (reported as  indication)(product use in unapproved indication) (strength, frequency, anatomical location of vaccination,route of administration, lot number, and expiration date were unknown by the reporter) (product administered to patient of inappropriate age).   It was reported that in December 2019, the patient had a change in her diagnosis to immunocompromised (immunodeficiency), and it was supposed to be administered to the patient a dose of pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13),  but received a second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) by mistake (extra dose administered, and wrong product administered). It was unknown if the patient received some treatment, laboratory diagnostics/studies were performed or if the patient received sought medical attention. The outcome of the event immunodeficiency was not reported.   The causality assessment between therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23), and the aforementioned event was not provided.   Upon internal review, the event immunodeficiency was considered to be medically significant.
This spontaneous report as received from a medical assistant refers to a 4 year old female patient. On 03-APR-2018 the patient was vaccinated with improperly stored dose of PROQUAD (lot#N031929, expiry date 12-MAY-2019) for prophylaxis. The vaccine was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT) (lot# N021030, expiry date 19-NOV-2019). No adverse effect was reported. The vaccine was exposed to the temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 41 hours and 17 minutes. No previous temperature excursion was involved. A data logger was present. No product quality complaint was present. This is one of the several reports received from the same reporter.
Fever, nausea, headache, light headed, muscle aches for 5 days.
Shoulder, back, neck aches Feeling out of sorts Trouble sleeping slight runny nose (left nostril) Occasionally pinch pain (left arm and shoulder) Cold sore (left nostril - same side of injection) Pain in right buttock
Redness, Swelling, and Bumps to the injection site.  Physician recommended Benadryl to help with any itching and the rash as well as Ibuprofen to help with any pain and the swelling.  Recommend the Ibuprofen every 6 hours for at least 24-48 hours and the benadryl every 6 hours as needed for itching.
Information has been received from a pharmacist concerning a male physician who on 19-JUL-2006 vaccinated himself with a dose of Varivax thinking it was the vaccine for herpes zoster. The pharmacist indicated that this was not an issue of product confusion. It was unknown if medical attention was sought. No adverse experiences have been related to this event. Additional information from the pharmacist indicated that she could not recall specific demographic information for the patient. She indicated that the physician called back and she believes that he did administer the "correct vaccine after all". She had no additional information. No additional information is expected.
Patient had arm pain for several days and fatigue, however they also developed fever blisters around their mouth which was the adverse reaction they were reporting.
This is a serious spontaneous case, initially received from other health professional on 01-Feb-2018, concerning a female patient of unspecified age. The patient's current condition included egg allergy. On an unspecified date, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, manufacturer, batch number and expiry date: unknown). On an unspecified date, after the vaccination, the patient had trouble in breathing and her throat was closed. The patient received EPIPEN and an unknown treatment. The patient had undergone an allergy test, at the time of these events. The reporter assessed the events (trouble in breathing and throat constriction) as related to suspect vaccine. The subject had recovered from the events.
On 1/9 noticed 2 medium size hives on right lower area near elbow, 1/10 additional hives on left lower area near elbow. Over the next few days several more hives appears on bilateral forearms. On 1/16 both arms were covered with hives that were itchy. On 1/17 both arms and legs covered with hives that were itchy. 1/18 went to PCP as hives increased in number and size and were itchy. Started on prednisone for allergic reaction